IFG Advisory’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-30,434
Closed -$2.9M 503
2021
Q3
$2.9M Buy
30,434
+4,466
+17% +$472K 0.31% 69
2021
Q2
$3.23M Buy
25,968
+7,398
+40% +$883K 0.36% 60
2021
Q1
$2.45M Sell
18,570
-4,421
-19% -$605K 0.3% 75
2020
Q4
$3.05M Sell
22,991
-64
-0.3% -$7.74K 0.42% 52
2020
Q3
$2.35M Buy
+23,055
New +$1.99M 0.38% 60
2020
Q2
Sell
-37,931
Closed -$2.2M 389
2020
Q1
$2.2M Sell
37,931
-9,873
-21% -$802K 0.49% 51
2019
Q4
$4.42M Buy
47,804
+7,781
+19% +$684K 0.81% 18
2019
Q3
$3.62M Sell
40,023
-7,652
-16% -$872K 0.7% 28
2019
Q2
$5.63M Sell
47,675
-2,424
-5% -$244K 1% 18
2019
Q1
$4.34M Buy
50,099
+800
+2% +$68.1K 0.83% 20
2018
Q4
$3.11M Sell
49,299
-3,783
-7% -$260K 0.73% 23
2018
Q3
$4.19M Sell
53,082
-39,310
-43% -$2.56M 0.79% 23
2018
Q2
$5.52M Sell
92,392
-25,919
-22% -$1.39M 1.14% 16
2018
Q1
$4.77M Sell
118,311
-10,101
-8% -$493K 1.06% 18
2017
Q4
$6.75M Buy
+128,412
New +$6.86M 1.52% 12

Other funds holding EXAS

IFG Advisory's EXAS Position: Q4 2021 in Review

IFG Advisory sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 30,434 shares — an estimated $2.9M sold.

IFG Advisory first reported a position in EXAS in Q4 2017 and held it in 15 quarters. The position peaked at $6.75M in Q4 2017. 595 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • IFG Advisory reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • IFG Advisory sold 30,434 Exact Sciences shares in Q4 2021, an estimated $2.9M.
  • IFG Advisory first reported a position in Exact Sciences in Q4 2017 and held it in 15 quarters.
  • IFG Advisory's Exact Sciences position peaked at $6.75M in Q4 2017.
  • 595 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on IFG Advisory's 13F filing for Q4 2021, filed 14 Feb 2022.